scholarly journals Treatment Outcomes after Discontinuation of Ethambutol due to Adverse Events in Mycobacterium avium Complex Lung Disease

2020 ◽  
Vol 35 (9) ◽  
Author(s):  
Yong Shik Kwon ◽  
Byoung Soo Kwon ◽  
Ock-hwa Kim ◽  
Yea Eun Park ◽  
Tae Sun Shim ◽  
...  
Keyword(s):  
Adverse Events ◽  
Lung Disease ◽  
Treatment Outcomes ◽  
Mycobacterium Avium ◽  
Mycobacterium Avium Complex

scholarly journals Clinical Management of Respiratory Adverse Events Associated With Amikacin Liposome Inhalation Suspension: Results From a Patient Survey

2020 ◽  
Vol 7 (4) ◽  
Author(s):  
Colin Swenson ◽  
Nicole C Lapinel ◽  
Juzar Ali
Keyword(s):  
United States ◽  
Adverse Events ◽  
Lung Disease ◽  
Mycobacterium Avium ◽  
Clinical Management ◽  
Mycobacterium Avium Complex ◽  
The United States ◽  
Patient Survey ◽  
Symptomatic Improvement

Abstract Patients with Mycobacterium avium complex lung disease treated with amikacin liposome inhalation suspension (ALIS) at 2 clinics in the United States were surveyed to assess the frequency and management of ALIS-associated respiratory adverse events. Most respondents experienced these events, but management through physician-guided measures (eg, bronchodilator use, oral rinses, and/or temporary dosing adjustments) resulted in symptomatic improvement.

scholarly journals Treatment Outcomes of Mycobacterium avium Complex Lung Disease: A Systematic Review and Meta-analysis

2017 ◽  
Vol 65 (7) ◽  
pp. 1077-1084 ◽  
Author(s):  
Nakwon Kwak ◽  
Jimyung Park ◽  
Eunyoung Kim ◽  
Chang-Hoon Lee ◽  
Sung Koo Han ◽  
...  
Keyword(s):  
Systematic Review ◽  
Lung Disease ◽  
Treatment Outcomes ◽  
Mycobacterium Avium ◽  
Mycobacterium Avium Complex ◽  
Meta Analysis
Sign in / Sign up

Export Citation Format

Share Document